A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability-Reference-Cited by-同舟云学术

A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability

Published:2024-05 Issue: Volume:202 Page:114033
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Moreau Mathilde,Alouani Emily^ORCID,Flecchia Clémence,Falcoz Antoine,Gallois Claire,Auclin Edouard,André Thierry^ORCID,Cohen Romain^ORCID,Hollebecque Antoine^ORCID,Turpin Anthony,Pernot Simon,Masson Thérèse,Di Fiore Frederic,Dutherge Marie,Mazard Thibault,Hautefeuille Vincent^ORCID,Van Laethem Jean-Luc,De la Fouchardière Christelle^ORCID,Perkins Géraldine,Ben-Abdelghani Meher^ORCID,Sclafani Francesco,Aparicio Thomas,Kim Stefano^ORCID,Vernerey Dewi,Taieb Julien,Guimbaud Rosine^ORCID,Tougeron David^ORCID

Publisher

Elsevier BV

Reference39 articles.

1. A molecular portrait of microsatellite instability across multiple cancers;Cortes-Ciriano;Nat Commun,2017

2. Landscape of microsatellite instability across 39 cancer types;Bonneville;JCO Precis Oncol,2017

3. Classification and characterization of microsatellite instability across 18 cancer types;Hause;Nat Med,2016

4. MSI phenotype and MMR alterations in familial and sporadic gastric cancer;Leite;Int J Cancer,2011

5. Very low incidence of microsatellite instability in intraductal papillary-mucinous neoplasm of the pancreas;Nakata;Int J Cancer,2002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the impact of aggregated autophagy-related genes TUBA1B and HSP90AA1 on colorectal cancer evolution: a single-cell sequencing study of the tumor microenvironment;Discover Oncology;2024-09-11

2. Clinical and Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein-Deficient Gastroesophageal Cancers;Annals of Surgical Oncology;2024-08-17